Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 22, 2021

SELL
$57.74 - $65.43 $217,737 - $246,736
-3,771 Closed
0 $0
Q3 2020

Nov 04, 2020

SELL
$57.43 - $63.64 $1.74 Million - $1.93 Million
-30,319 Reduced 88.94%
3,771 $227,000
Q2 2020

Jul 07, 2020

BUY
$54.82 - $64.09 $409,231 - $478,431
7,465 Added 28.04%
34,090 $2.05 Million
Q4 2019

Feb 03, 2020

BUY
$49.21 - $64.19 $1.31 Million - $1.71 Million
26,625 New
26,625 $1.68 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Platte River Wealth Advisors, LLC Portfolio

Follow Platte River Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platte River Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Platte River Wealth Advisors, LLC with notifications on news.